272 related articles for article (PubMed ID: 30257870)
1. Angelman syndrome-associated point mutations in the Zn
Kühnle S; Martínez-Noël G; Leclere F; Hayes SD; Harper JW; Howley PM
J Biol Chem; 2018 Nov; 293(47):18387-18399. PubMed ID: 30257870
[TBL] [Abstract][Full Text] [Related]
2. A proteasomal partner goes missing in Angelman syndrome.
Huibregtse JM
J Biol Chem; 2018 Nov; 293(47):18400-18401. PubMed ID: 30470726
[TBL] [Abstract][Full Text] [Related]
3. Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome.
Tomaić V; Banks L
Cell Death Dis; 2015 Jan; 6(1):e1625. PubMed ID: 25633294
[TBL] [Abstract][Full Text] [Related]
4. The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasome.
Yi JJ; Paranjape SR; Walker MP; Choudhury R; Wolter JM; Fragola G; Emanuele MJ; Major MB; Zylka MJ
J Biol Chem; 2017 Jul; 292(30):12503-12515. PubMed ID: 28559284
[TBL] [Abstract][Full Text] [Related]
5. Zn-binding AZUL domain of human ubiquitin protein ligase Ube3A.
Lemak A; Yee A; Bezsonova I; Dhe-Paganon S; Arrowsmith CH
J Biomol NMR; 2011 Sep; 51(1-2):185-90. PubMed ID: 21947926
[TBL] [Abstract][Full Text] [Related]
6. Structure of E3 ligase E6AP with a proteasome-binding site provided by substrate receptor hRpn10.
Buel GR; Chen X; Chari R; O'Neill MJ; Ebelle DL; Jenkins C; Sridharan V; Tarasov SG; Tarasova NI; Andresson T; Walters KJ
Nat Commun; 2020 Mar; 11(1):1291. PubMed ID: 32157086
[TBL] [Abstract][Full Text] [Related]
7. Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants.
Offensperger F; Müller F; Jansen J; Hammler D; Götz KH; Marx A; Sirois CL; Chamberlain SJ; Stengel F; Scheffner M
Cell Chem Biol; 2020 Dec; 27(12):1510-1520.e6. PubMed ID: 32966807
[TBL] [Abstract][Full Text] [Related]
8. E6AP AZUL interaction with UBQLN1/2 in cells, condensates, and an AlphaFold-NMR integrated structure.
Buel GR; Chen X; Myint W; Kayode O; Folimonova V; Cruz A; Skorupka KA; Matsuo H; Walters KJ
Structure; 2023 Apr; 31(4):395-410.e6. PubMed ID: 36827983
[TBL] [Abstract][Full Text] [Related]
9. Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein.
Cooper EM; Hudson AW; Amos J; Wagstaff J; Howley PM
J Biol Chem; 2004 Sep; 279(39):41208-17. PubMed ID: 15263005
[TBL] [Abstract][Full Text] [Related]
10. An Angelman syndrome substitution in the HECT E3 ubiquitin ligase C-terminal Lobe of E6AP affects protein stability and activity.
Beasley SA; Kellum CE; Orlomoski RJ; Idrizi F; Spratt DE
PLoS One; 2020; 15(7):e0235925. PubMed ID: 32639967
[TBL] [Abstract][Full Text] [Related]
11. The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer.
Ronchi VP; Klein JM; Edwards DJ; Haas AL
J Biol Chem; 2014 Jan; 289(2):1033-48. PubMed ID: 24273172
[TBL] [Abstract][Full Text] [Related]
12. Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome.
Avagliano Trezza R; Sonzogni M; Bossuyt SNV; Zampeta FI; Punt AM; van den Berg M; Rotaru DC; Koene LMC; Munshi ST; Stedehouder J; Kros JM; Williams M; Heussler H; de Vrij FMS; Mientjes EJ; van Woerden GM; Kushner SA; Distel B; Elgersma Y
Nat Neurosci; 2019 Aug; 22(8):1235-1247. PubMed ID: 31235931
[TBL] [Abstract][Full Text] [Related]
13. Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10.
Lee SY; Ramirez J; Franco M; Lectez B; Gonzalez M; Barrio R; Mayor U
Cell Mol Life Sci; 2014 Jul; 71(14):2747-58. PubMed ID: 24292889
[TBL] [Abstract][Full Text] [Related]
14. Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.
Bossuyt SNV; Punt AM; de Graaf IJ; van den Burg J; Williams MG; Heussler H; Elgersma Y; Distel B
Hum Mol Genet; 2021 Apr; 30(6):430-442. PubMed ID: 33607653
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic Ube3a E3 ligase promotes synapse elimination through down-regulation of BMP signaling.
Furusawa K; Ishii K; Tsuji M; Tokumitsu N; Hasegawa E; Emoto K
Science; 2023 Sep; 381(6663):1197-1205. PubMed ID: 37708280
[TBL] [Abstract][Full Text] [Related]
16. Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes.
Martínez-Noël G; Galligan JT; Sowa ME; Arndt V; Overton TM; Harper JW; Howley PM
Mol Cell Biol; 2012 Aug; 32(15):3095-106. PubMed ID: 22645313
[TBL] [Abstract][Full Text] [Related]
17. Cobalamins Function as Allosteric Activators of an Angelman Syndrome-Associated UBE3A/E6AP Variant.
Müller F; Jansen J; Offensperger F; Eichbichler D; Stengel F; Scheffner M
Chembiochem; 2024 May; 25(10):e202400184. PubMed ID: 38573110
[TBL] [Abstract][Full Text] [Related]
18. Loss of Angelman Syndrome Protein E6AP Disrupts a Novel Antagonistic Estrogen-Retinoic Acid Transcriptional Crosstalk in Neurons.
El Hokayem J; Weeber E; Nawaz Z
Mol Neurobiol; 2018 Sep; 55(9):7187-7200. PubMed ID: 29388081
[TBL] [Abstract][Full Text] [Related]
19. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
Drews CM; Brimer N; Vande Pol SB
PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
[TBL] [Abstract][Full Text] [Related]
20. Angelman syndrome scientific symposium on the structure and function of UBE3A/E6AP.
Williams C
J Child Neurol; 2009 Jul; 24(7):904-8. PubMed ID: 19617463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
